Thursday, November 12, 2009 |
18:30-20:00
|
Welcome Reception |
Friday, November 13, 2009 |
08:30-10:00 |
Keynote Lectures Advances in Obstetrics, Gynecology and Infertility: Leaders' Views on the Future |
Capsule
|
What does the future hold for our main subdisciplines?
|
| Chairpersons | Z. Ben-Rafael, Israel
V. Gomel, Canada
G.C. Di Renzo, Italy
|
|
08:30-09:00 |
T-H. Bui, Sweden
|
| 09:00-09:30 |
Gynecology Surgical approach for endometriosis, do we have limits? F. Nezhat, USA
|
| 09:30-10:00 |
Infertility & ART
R. Fadini, Italy
|
| 10:00-10:30 | Coffee break
|
| 10:30-12:30 | Fostimon, human-type FSH: From basic science to clinical practice
Sponsored by IBSA Institut Biochimique SA |
| Chairpersons | Z.J. Chen, China
J.L.H. Evers, The Netherlands V. Gomel, Canada |
| 10:30-10:35 | Introduction
|
| 10:35-10:55 |
|
| 10:55-11:15 | Structure-activity relationship of FSH molecular species: Focus on glycosylation
M. Dattilo, Switzerland |
| 11:15-11:35 | Effect of FSH stimulation regimens on the pattern of mRNA expression in human cumulus cells
M. Benkhalifa, France |
| 11:35-11:55 |
|
| 11:55-12:15 |
|
| 12:15-12:30 | Discussion and conclusions
|
| 12:30-13:30 | Lunch break
|
| 13:30-15:30 | Cryopreservation of Gametes and Ovaries |
| Capsule | The best clinical method for cryopreservation of oocytes and ovarian tissue is yet to be decided
|
| Chairperson | S.A. Carson, USA
J. Donnez, Beligum
|
| 13:30-14:30 | Debate
Human Oocyte Cryopreservation: Slow Freezing or Verification Techniques
Human oocyte cryopreservation: The slow-freezing technique A. Borini, Italy Human oocyte cryopreservation: Vitrification technique R. Fadini, Italy |
14:30-15:00
|
Freezing whole human ovaries
P. Patrizio, USA |
15:00-15:30 |
The advantages of zygote vitrification
T. Cordes, Germany |
| 15:30-16:00 | Coffee Break
|
| 16:00-18:00 | Assessment of Ovarian Reserve |
| Capsule | Decreased ovarian reserve remains a common and frustrating condition despite years of experience. Can we evaluate and provide better treatment?
|
| Chairpersons | K. Diedrich, Germany
I.E. Messinis, Greece
C.Q. Zhou, China
|
16:00-16:25 |
A. Maheshwari, UK
|
| 16:25-16:50 |
N. Gleicher, USA
|
| 16:50-17:15 |
K. Kawano, Japan
|
17:15-18:00
|
Debate
Proposition: No treatment options for decreased ovarian reserve and low responders are effective. It is only cycle-to-cycle variation that is of importance!
P. Patrizio, USA
Opposition: Better protocols will result in better pregnancy rates! S. Daya, Canada
Discussion |
Saturday, November 14, 2009 |
|
| 08:30-10:00 | Clinical Application of the Gamete Freezing |
| Capsule | The rising efficacy of gamete freezing facilitates diversification of clinical solutions
Organized and endorsed by IVI (Instituto Valenciano de Infertilidad)
|
| Chairpersons | P. Patrizio USA
A. Requena, Spain
|
| 08:30-09:00 |
|
| 09:00-09:30 | Delaying childbearing: An increasing demand for egg freezing
A. Requena, Spain |
| 09:30-10:00 | What are the reproductive options for males suffering from cancer?
N. Garrido, Spain |
| 10:00-10:30 | Coffee Break
|
|
10:30-12:30
|
|
Capsule |
Expert opinions on controversial topics
|
| Chairpersons | Z. Ben-Rafael, Israel
K. Diedrich, Germany |
Z.J. Chen, China
S.A. Carson, USA J. Qiao, China N. Gleicher, USA S. Daya, Canada
G. Kovacs, Australia |
|
| Questions | > Evidence based supplementation of the corpus luteum in IVF?
> Minimal monitoring of ovarian stimulation: Is it safe? How minimal?
> Cheap or expensive FSH preparations?
> Why did the antagonist not replace the agonist?
> Do we need the addition of luteinizing hormone (LH) for ovarian stimulation?
> Risk of ovarian hyperstimulation syndrome (OHSS): Is it a real problem?
> Intracytoplasmic sperm injection (ICSI) for all patients?
> Is rescue ICSI effective in conventional IVF or ICSI?
> Assisted zona hatching: What is the evidence?
> Embryo transfer (ET); Do we really need US?
> Is the ET technique important?
> Single embryo transfer (SET) for all?
> Is there a risk of cancer after ovarian stimulation?
|
| 12:30-13:30 | Lunch break
|
13:30-15:30
|
Infertility Practice |
| Capsule | Many practical issues are still unsettled
|
| Chairpersons | S. Daya, Canada
G. Kovacs, Australia
|
| 13:30-14:00 |
|
| 14:00-14:30 |
K. Ntafopoulos, Greece
|
| 14:30-15:00 | The role of LH in ovarian stimulation
I.E. Messinis, Greece |
15:00-15:30 |
|
| 15:30-16:00 | Coffee Break
|
16:00-18:00 |
Polycystic Ovarian Syndrome (PCOS) in the Asia-Pacific Region |
| Capsule | Disagreement regarding basic criteria for definition of PCOS, are also region dependent?
Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG) |
| Chairpersons | P.C. Ho, Hong Kong
N. Gleicher, USA
Z.J. Chen, China
|
| 16:00-16:45 | Views: Do we need a different set of criteria for defining PCOS in this region?
Views from East Asia M. Hsu, Taiwan Views from South Asia D. Shah, India Discussion |
| 16:45-17:30 | Views: Do we need different treatment for Asian PCOS?
J.Tank, India J. Qiao, China Discussion |
17:30-18:00 |
Can we prevent OHSS syndrome? H. Sallam, Egypt |
18:30-20:00 |
"Voices" Special Entertainment Lecture by Dr. C.O. (Skip) Granai, USA |
Sunday, November 15, 2009 |
|
| 08:30-10:00 | In-Vitro Maturation (IVM) |
| Capsule | Despite many improvements, IVM is still experimental: Risk benefits and pitfalls should be clarified
|
| Chairpersons | A. Borini, Italy
E. Ng, Hong Kong
|
| 08:30-09:30 | Debate
Will IVM Ever Replace Standard IVF?
Yes: IVM should be an integral part of IVF Service
M. Leong, Hong Kong No: IVM does not offer any advantage over current IVF practice K.R. Held, Germany |
|
09:30-10:00 |
R. Fadini, Italy
|
| 10:00-10:30 | Coffee break
|
| 10:30-12:30 | Increasing Success Rate in ART |
| Capsule | Can better laboratory techniques bring about a breakthrough in success rate?
Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG)
|
| Chairpersons | H.N. Sallam, Egypt
M. Leong, Hong Kong
|
| 10:30-11:30 | Debate
The end of the Preimplantation Genetic Screening (PGS) Era?
Pros: PGS is associated with lower success rate and should not be offered as a screening tool! N. Gleicher, USA Cons: PGS has a role provided it correctly performed! K.R. Held, Germany |
11:30-12:00 |
|
| 12:00-12:30 | |